InspackBook a demo
Telehealth compliance

Every claim checked before FDA does

AI compliance review for everything your telehealth brand publishes, from vial labels to landing pages.

Try for free
Telehealth landing page with three GLP-1 claims flagged by Inspack.

We check all of it

What we check

  • Vial and box labels
  • Patient inserts
  • Website and landing pages
  • Paid social and search ads
  • Emails and SMS
  • Influencer and affiliate scripts

Against what

  • FDA drug promotion rulesauto-updated
  • FTC health claimsauto-updated
  • State AG and pharmacy board rulesby state where you sell
  • Your brand and legal guidelinesturned into checks

Every issue comes with

  • the rule behind it
  • a suggested fix
  • a full audit trail

“Inspack checks every launch before it goes live. Legal now sees 70% fewer drafts, and we’ve had zero warning letters in 12 months.”

Jonathan RowelFounder, GLP-1 brand

01 / The problem

Staying compliant is slowing you down

01

Rules keep moving

FDA and FTC expectations shift faster than any playbook.

02

Lawyers are expensive

Every label, page and ad through counsel adds up fast.

03

Reviews take weeks

Launches wait in a queue while competitors ship.

04

One miss goes public

A single claim can end up in a warning letter on FDA’s website.

02 / How it works

From upload to approval in minutes

01Upload

Add materials and pick rules

Upload labels, pages, ads or emails. Choose your rules or use the ones we suggest.

GLP-1 launch, October4 files added
  • Vial labelSemaglutide 2.5 mg/mL
    Added
  • Patient insertPatient information
    Added
  • Landing pageMedical weight loss, delivered
    Added
  • Instagram adLose up to 15% body weight
    Added
02Review

Check findings and fixes

See every risky claim, the rule behind it and a suggested fix.

Findings3 open
  • Implies equivalence to an FDA-approved drugFDA misbranding
    Issue
  • FDA doesn’t approve pharmaciesFDA misbranding
    Issue
  • Trial results don’t carry over to compounded drugsFTC substantiation
    Issue
03Approve

Approve and ship

Route to legal in one click. Every decision is logged.

03 / Rules

Checked against what matters to you

01Regulators

Kept current with the regulators

We follow 100+ regulatory sources. When guidance changes, the affected checks update automatically, and our regulatory experts review them.

Regulation libraryAuto-updated
  • Compounded drug promotionFDA · FDCA 502(a) and 502(bb), US
    Updated
  • Health claims and substantiationFTC · FTC Act Section 5, US
    Updated
  • 503A and 503B labelingFDA · Compounded drug labels, US
    On
  • State pharmacy board rulesBOP · Advertising, by state
    On
02Your rules

Your rules, built in

Upload your brand guidelines, creative briefs or legal playbook. Inspack turns them into checks that run on every review.

Northline brand and legal guide4 checks created
  • Never call compounded drugs “generic”
    On
  • Add “Compounded drugs are not FDA-approved” to GLP-1 pages
    On
  • Say “provider”, not “doctor”
    On
  • Use the approved product name on every label
    On

Try Inspack free for 7 days

Run your own labels, pages and ads through the tool. Set up in 5 minutes, no commitment.

Start free trialSee Inspack pricing

04 / FAQ

Telehealth compliance, answered

No. Inspack is the first pass, so legal only sees clean drafts. It doesn’t give legal advice.

FDA drug promotion and labeling rules, FTC health claim rules, and your own brand and legal guidelines.

Labels, inserts, packaging, web pages, ads, emails, SMS and influencer scripts.

Yes. Check your corrected content before it goes live, and keep new content from repeating the same claims.

No. We review marketing and packaging content, not medical records.

05 / Resources

Latest on Inspack

Exploring AI, compliance, and packaging validation practices

Read more
Read more